Diabetes Mellitus, Type 2Phase 4NCT01897532
Cardiovascular and Renal Microvascular Outcome Study With Linagliptin in Patients With Type 2 Diabetes Mellitus (CARMELINA)
A Phase 4 study testing Linagliptin in people with Diabetes Mellitus, Type 2, run by Boehringer Ingelheim at 649 sites in 27 countries.
Trial summary
The aim of the study is to investigate the longterm impact on cardiovascular morbidity, mortality and renal function of treatment with linagliptin in a selected population of patients with Type 2 diabetes mellitus (T2DM) and to compare outcomes against placebo, on a background of standard of care. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Diabetes Mellitus, Type 2
- What is being tested?
- Linagliptin
- Type of treatment
- Pill or oral medicine
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 6,991 participants
- Where
- 649 sitesin 27 countries
- Study dates
- 10 Jul 2013to 18 Jan 2018
- Phase
- Phase 4
- Are there results?
- Yes, posted in the registrySummary in the doctors' view
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Documented diagnosis of T2DM before visit 1(screening).
- Male or female patients who are drug-naïve or pre-treated with any antidiabetic background medication, excluding treatment with Glucagon-like Peptide 1 (GLP-1) receptor agonists, Dipeptidyl-peptidase 4 (DPP-4) inhibitors or Sodium Glucose Linked Transporter 2 (SGLT-2) inhibitors if => consecutive 7 days.
- Stable antidiabetic background medication (unchanged daily dose) for at least 8 weeks prior to randomization. If insulin is part of the background therapy, the average daily insulin dose should not have changed by more than 10% within the 8 weeks prior to randomization compared with the daily insulin dose at randomization.
- HbA1c of => 6.5% and <= 10.0% at Visit 1 (screening)
- Age => 18 years at Visit 1(screening). For Japan only: Age => 20 years at Visit 1
- Body Mass Index (BMI) <= 45 kg/m2 at Visit 1 (screening)
- Signed and dated written informed consent by date of Visit 1(screening) in accordance with Good Clinical Practice (GCP) and local legislation prior to any study related procedure
- High risk of cardiovascular (CV) events defined by: 1) albuminuria (micro or macro) and previous macrovascular disease and/or 2) impaired renal function with predefined Urine Albumin Creatinine Ratio (UACR)
Who cannot join
- Type 1 diabetes mellitus.
- Treatment (=> 7 consecutive days) with GLP-1 receptor agonists, other DPP-4 inhibitors or SGLT-2 inhibitors prior to informed consent. Note: This also includes clinical trials where these antidiabetic drugs have been provided to the patient.
- Active liver disease or impaired hepatic function, defined by serum levels of either Alanine Transaminase (ALT) (SGPT), Aspartate transaminase (AST) (SGOT), or alkaline phosphatase (AP) => 3 x upper limit of normal (ULN) as determined at Visit 1.
- Estimated Glomerular filtration Rate (eGFR) <15 ml/min/1.73 m2 (severe renal impairment or End Stage Renal Disease (ESRD), Modification of Diet in Renal Disease (MDRD) formula), as determined during screening at Visit 1 and/or the need for maintenance dialysis.
- Any previous (or planned within next 12 months) bariatric surgery (open or laparoscopic) or intervention (gastric sleeve).
- Pre-planned coronary artery re-vascularisation (PCI, CABG) or any previous PCI and/or CABG <= 2 months prior informed consent.
Show all 13Show fewer
- Known hypersensitivity or allergy to the investigational products or its excipients.
- Any previous or current alcohol or drug abuse that would interfere with trial participation in the opinion of the investigator.
- Participation in another trial with an investigational drug ongoing or within 2 months prior to visit 1 (screening).
- Pre-menopausal women (last menstruation = 1 year prior to informed consent) who are nursing or pregnant, are of child-bearing potential and are not practicing an acceptable method of birth control (acceptable methods of birth control include tubal ligation, transdermal patch, intra uterine devices/systems (IUDs/IUSs), oral, implantable or injectable contraceptives, sexual abstinence (if allowed by local authorities), double barrier method and vasectomised partner) or do not plan to continue using acceptable method of birth control throughout the study and do not agree to submit to periodic pregnancy testing during participation in the trial.
- Patients considered unreliable by the investigator concerning the requirements for follow up during the study and/or compliance with study drug administration, have a life expectancy less than 5 years for non-CV causes, or have cancer other than non-melanoma skin cancer within last 3 years, or has any other condition than mentioned which in the opinion of the investigator, would not allow safe participation in the study.
- Acute coronary syndrome (ACS), diagnosed <= 2 months prior to visit 1 (screening).
- Stroke or Transient Ischemic Attack (TIA) <= 3 months prior to visit 1 (screening).
Trial locations and contacts
649 sites in 27 countries.
649 sites in 27 countries
United States197 sites
Summa Health System
Akron, Ohio, 44304
New Mexico Clinical Research and Osteoporosis Center, Inc.
Albuquerque, New Mexico, 87106
Endeavor Medical Research
Alpena, Michigan, 49707
Blair Medical Associates
Altoona, Pennsylvania, 16602
Clinical Research Associates of Central Pennsylvania
Altoona, Pennsylvania, 16602
University of Michigan Health System
Ann Arbor, Michigan, 48105
Western Nephrology & Metabolic
Arvada, Colorado, 80002
Emory University
Atlanta, Georgia, 30303
Laureate Clinical Research Group, LLC
Atlanta, Georgia, 30308
DCT- AACT, LLC dba Discovery Clinical Trials
Austin, Texas, 78758
American Health Network
Avon, Indiana, 46123
Bainbridge Medical Associates
Bainbridge, Georgia, 39819
Maryland Cardiovascular Specialists
Baltimore, Maryland, 21229
Overlea Personal Physicians
Baltimore, Maryland, 21236
Johns Hopkins University
Baltimore, Maryland, 21287
Rockwood Medical Clinic
Bedford, Texas, 76022
Belleville Family Medical Associates, Ltd
Belleville, Illinois, 62220
Kaiser Permanente - San Diego, Bonita
Bonita, California, 91902
Helix Biomedics LLC
Boynton Beach, Florida, 33435
Orthopedic Research Institute
Boynton Beach, Florida, 33437
Nova Clinical Research, LLC
Bradenton, Florida, 34209
PAB Clinical Research
Brandon, Florida, 33511
Holston Medical Group
Bristol, Tennessee, 37620
Life Medi-Research and Management
Brooklyn, New York, 11206
Meridien Research
Brooksville, Florida, 34601
Burke Internal Medicine and Research
Burke, Virginia, 22015
Kernodle Clinic West
Burlington, North Carolina, 27215
Main Street Physicians Care
Calabash, North Carolina, 28467
Medical Frontiers, LLC
Carlisle, Ohio, 45005
Mississippi Medical Research, LLC
Carriere, Mississippi, 39426
Clinical Trials of South Carolina
Charleston, South Carolina, 29406
Medical University of South Carolina
Charleston, South Carolina, 29425
Box Arthritis & Rheumatology of the Carolinas
Charlotte, North Carolina, 28210
Cedar-Crosse Research Center
Chicago, Illinois, 60607
Chicago Clinical Research Institute, Inc.
Chicago, Illinois, 60607
Southeast Clinical Research, LLC
Chiefland, Florida, 32626
BayCare Medical Group
Clearwater, Florida, 33756
Ericksen Research & Development, LLC
Clinton, Utah, 84015
John Muir Physician Network Clinical Research Center
Concord, California, 94520
The Corvallis Clinic, PC
Corvallis, Oregon, 97330
Atlanta Heart Specialists, LLC
Cumming, Georgia, 30041
Texas Health Physicians Group
Dallas, Texas, 75218
Research Institute of Dallas
Dallas, Texas, 75231
Dayton VA Medical Center
Dayton, Ohio, 45428
McGarity, Jr., William C.
Decatur, Georgia, 30035-4000
Cohen Medical Research Associates, LLC
Delray Beach, Florida, 33446
South Denver Nephrology
Denver, Colorado, 80210
Innovation Medical Research Center, Inc
Doral, Florida, 33166
Central Bucks Cardiology
Doylestown, Pennsylvania, 18901
Doylestown Health Cardiology
Doylestown, Pennsylvania, 18901
Focus Clinical Research
Draper, Utah, 84020
Associates in Endocrinology, Incorporated
Elgin, Illinois, 60124
USMA Clin. Research/Union Square Med. Associates
Elizabeth, New Jersey, 07201
Aa Mrc Llc
Flint, Michigan, 48504
Integrative Research Associates
Fort Lauderdale, Florida, 33312
Jellinger and Lerman, MD, PA dba The Center for Diabetes and Endocrine Care
Fort Lauderdale, Florida, 33312
American Health Network of Indiana, LLC
Franklin, Indiana, 46131
Valley Research
Fresno, California, 93720
Spectrum Medical Research, LLC
Gaffney, South Carolina, 29341
Clinical Research of Gastonia
Gastonia, North Carolina, 28054
Arrowhead Health Centers
Glendale, Arizona, 85306
Colorado Center for Bone Research, P.C.
Golden, Colorado, 80401
American Health Network of Indiana, LLC
Greenfield, Indiana, 46140
Medication Management, LLC
Greensboro, North Carolina, 27408
VitaLink Research
Greenville, South Carolina, 29615
Mountain View Clinical Research
Greer, South Carolina, 29651
Harrisburg Family Medical Center
Harrisburg, Arkansas, 72432
Nova Health Management & Research Group, PC
Herndon, Virginia, 20170
Direct Helpers Medical Center, Inc
Hialeah, Florida, 33012
Universal Clinical Research
Hialeah, Florida, 33012
PMG Research of Bristol, LLC
Hickory, North Carolina, 28601
Homestead Associates in Research
Homestead, Florida, 33032
Ben Taub General Hospital
Houston, Texas, 77030
Southwest Clinical Trials
Houston, Texas, 77074
The Endocrine Center
Houston, Texas, 77079
Texas Family Geriatrics Clinic
Houston, Texas, 77082
Memorial Clinical Associates Research
Houston, Texas, 77084
Longwood Research
Huntsville, Alabama, 35801
Break Through Medical Research
Irving, Texas, 75039
Medical & Surgical Clinic
Irving, Texas, 75061
St. Vincent's Cardiology
Jacksonville, Florida, 32216
Care Partners Clinical Research LLC
Jacksonville, Florida, 32277
Lycoming Internal Medicine, Inc
Jersey Shore, Pennsylvania, 17740
United Medical Associates
Johnson City, New York, 13901
State of Franklin Healthcare Associates, PLLC
Johnson City, Tennessee, 37604
Kidney Care Center, Nephrology
Joliet, Illinois, 60435
Glacier View Cardiology, PC
Kalispell, Montana, 59901
Truman Medical Centers, Inc.
Kansas City, Missouri, 64108
Kansas City Veterans Administration Medical Center
Kansas City, Missouri, 64128
West Memorial Family Practice
Katy, Texas, 77450
Altus Research, Inc.
Lake Clarke Shores, Florida, 33406
Meridien Research
Lakeland, Florida, 33805
Alas Science Clinical Research
Las Vegas, Nevada, 89120
The Research Group of Lexington, LLC
Lexington, Kentucky, 40503
Mount Sinai - PRIME
Linden, New Jersey, 07036
Cardiology and Medicine Clinic
Little Rock, Arkansas, 72204
Little Rock Diagnostic Clinic
Little Rock, Arkansas, 72205
VA Loma Linda Healthcare System
Loma Linda, California, 92357
Long Beach Center for Clinical Research
Long Beach, California, 90807
Clearview Medical Research, LLC
Los Angeles, California, 90019
National Research Institute
Los Angeles, California, 90057
Office of Dr. Richard S. Cherlin
Los Gatos, California, 95032
Coastal Medical Research Group
Los Osos, California, 93402
Manassas Clinical Research Center
Manassas, Virginia, 20110
Diabetes and Metabolism Associates APMC
Metairie, Louisiana, 70006
Clinical Research of Miami
Miami, Florida, 33126
Prestige Clinical Research Center, Inc.
Miami, Florida, 33133
Jesscan Medical Research, Internal Medicine
Miami, Florida, 33134
Clintex Research Group, Inc. Research
Miami, Florida, 33135
University of Miami
Miami, Florida, 33136
Florida Medical Center & Research Inc
Miami, Florida, 33142
A+ Research Incorporated
Miami, Florida, 33144
Unlimited Medical Research, LLC
Miami, Florida, 33144
Regenerate Clinical Trials
Miami, Florida, 33155
Sanitas Research
Miami, Florida, 33155
Future Care Solution, LLC
Miami, Florida, 33165
Research Institute of South Florida Inc
Miami, Florida, 33173
Tellus Clinical Research, Incorporated
Miami, Florida, 33173
New Horizon Research Center
Miami, Florida, 33175
Kendall South Medical Center, Inc
Miami, Florida, 33185
Coral Research Clinic Corp
Miami, Florida, 33186
Precision Research Organization
Miami Lakes, Florida, 33016
Zablocki VA Medical Center
Milwaukee, Wisconsin, 53295
Novo Research, Incorporated
Modesto, California, 95350
Novant Health Southern Piedmont Primary Care
Monroe, North Carolina, 28110
Research Institute of the Carolinas, PLC
Mooresville, North Carolina, 28117
Down East Medical Associates
Morehead City, North Carolina, 28557
Burke Primary Care
Morganton, North Carolina, 28655
American Health Network of Indiana, LLC
Muncie, Indiana, 47304
Hill Country Medical Associates
New Braunfels, Texas, 78130
Tulane University Hospital and Clinic
New Orleans, Louisiana, 70112
Providence Clinical Research
North Hollywood, California, 91606
School of Clinical Research
North Miami Beach, Florida, 33144
Harmony Clinical Research, Incorporated
North Miami Beach, Florida, 33162
Platte River Nephrology
North Platte, Nebraska, 69101
Northridge Clinical Research Inc.
Northridge, California, 91324
Norton Community Care
Norton, Ohio, 44203
Magnolia Research Group
Ocala, Florida, 34471
Carr Cardiology
Oceanside, California, 92056
Permian Research Foundation
Odessa, Texas, 79761
Advanced Research Institute
Ogden, Utah, 84405
Paramount Medical Care
Ogden, Utah, 84405
COR Clinical Research, LLC
Oklahoma City, Oklahoma, 73103
Lynn Health Science Institute
Oklahoma City, Oklahoma, 73112
Omaha Veterans Affairs Medical Center
Omaha, Nebraska, 68131
Family Medical Center
Orlando, Florida, 32806
Peninsula Research, Inc.
Ormond Beach, Florida, 32174
Methodist Hospital Research Institute, Internal Medicine
Pearland, Texas, 77584
McLaren Northern Michigan Hospital
Petoskey, Michigan, 49770
Precision Trials, LLC
Phoenix, Arizona, 85032
Infinity Clinical Research, LLC
Plantation, Florida, 33317
Sound Medical Research
Port Orchard, Washington, 98366
Health Concepts
Rapid City, South Dakota, 57702
Dominion Medical Associates, Inc.
Richmond, Virginia, 23219
Hunter Holmes McGuire Veterans Administration Medical Center
Richmond, Virginia, 23249
Roanoke Heart Institute PLC
Roanoke, Virginia, 24014
Remedica LLC
Rochester, Michigan, 48307
Vita Link Research- Rock Hill
Rock Hill, South Carolina, 29732
Center for Clinical Trials of Sacramento, Incorporated
Sacramento, California, 95823
HealthEast St. Joseph's Hospital
Saint Paul, Minnesota, 55102
Salem Veterans Affairs Medical Center
Salem, Virginia, 24153
Delmarva Heart Research Foundation, Inc
Salisbury, Maryland, 21804
PMG Research of Salisbury, LLC
Salisbury, North Carolina, 28144
Health Texas Research Institute
San Antonio, Texas, 78228-6205
Covenant Clinical Research, PA
San Antonio, Texas, 78229
DM Clinical Research
San Antonio, Texas, 78249
DCT-Stone Oak, LLC dba Discovery Clinical Trials
San Antonio, Texas, 78258
North America Research Institute
San Dimas, California, 91773
Trinitas Research, Incorporated
San Jose, California, 95116
Intercoastal Medical Group, Endocrinology
Sarasota, Florida, 34232
Saratoga Clinical Research, LLC
Saratoga Springs, New York, 12866
Scottsboro Quick Care Clinic
Scottsboro, Alabama, 35768
Sealy Urgent Care Center and Medical Clinic
Sealy, Texas, 77474
Montgomery Medical Incorporated
Smithfield, Pennsylvania, 15478
Apex Medical Research, AMR, Incorporated
Springfield, Ohio, 45505
Meridien Research
St. Petersburg, Florida, 33709
Professional Health Care of Pinellas, Inc.
St. Petersburg, Florida, 33713
Tri-County Research, Inc
Sterling Heights, Michigan, 48310-3503
Pioneer Research Solutions, Inc.
Sugar Land, Texas, 77479
Meridien Research
Tampa, Florida, 33634
Metabolic Institute of America
Tarzana, California, 91356
Jacobi Medical Center
The Bronx, New York, 10461
ProMedica Health Education & Research Corp.
Toledo, Ohio, 43606
DM Clinical Research
Tomball, Texas, 77375
Cotton-O'Neil Clinical Research Center
Topeka, Kansas, 66606
Oakland Medical Research Center
Troy, Michigan, 48085
Atlanta Heart Specialists, LLC
Tucker, Georgia, 30084
Office of Dr. Terence T. Hart MD
Tuscumbia, Alabama, 35674
Buynak Clinical Research
Valparaiso, Indiana, 46383
Crossroads Clinical Research, LLC
Victoria, Texas, 77901
Northeast Iowa Medical Education Foundation
Waterloo, Iowa, 50702
Center for Clinical Trials of San Gabriel
West Covina, California, 91790
Iowa Diabetes and Endocrinology Research Center
West Des Moines, Iowa, 50265
Metabolic Research Institute
West Palm Beach, Florida, 33401
Professional Research Network of Kansas, LLC
Wichita, Kansas, 67203
Heartland Research Associates, LLC
Wichita, Kansas, 67205
Natalie A Doyle, M.D., P.A.
Wilson, North Carolina, 27893
Argentina55 sites
Instituto Médico Adrogué
Adrogué, B1846DSK
Hospital Interzonal General de Agudos Dr Jose Penna
Bahía Blanca, 8000
Inst de Inv Clinicas-Bahia Blanca
Bahía Blanca, B8000FTD
Hospital Italiano Regional del Sur, Bahia Blanca
Bahía Blanca, B8001HXM
Hospital Sirio-Libanés
Caba, C1419GEP
Centro de Investigaciones Metabólicas
Ciudad Autonoma Buenos Aires, C1056ABJ
CIPREC
Ciudad Autonoma Buenos Aires, C1119ACN
Hospital Italiano
Ciudad Autonoma Buenos Aires, C1181ACH
Consultorios Asociados de Endocrinología e Invest Clínica
Ciudad Autonoma Buenos Aires, C1425AGC
CEDIC - Centro de Investigacion Clinica
Ciudad Autonoma Buenos Aires, C1425DES
Instituto Cardiovascular de Buenos Aires
Ciudad Autonoma Buenos Aires, C1428ART
CCBR - Buenos Aires - AR
Ciudad Autonoma Buenos Aires, C1430CKE
Centro Médico Viamonte
Ciudad Autonoma de Bs As, C1120AAC
Centro Médico Colon
Córdoba, 5000
CEMAIC - Centro Medico Especializado
Córdoba, 5008
Inst. Privado de Inv. Clínicas de Córdoba
Córdoba, X5000AAW
Sanatorio Allende S.A.
Córdoba, X5000JHQ
Clínica Colombo
Córdoba, X5002AOQ
Instituto DAMIC - Fundacion Rusculleda
Córdoba, X5003DCE
Hospital Cordoba
Córdoba, X5004CDT
IPAC - Clínica Privada Caraffa SRL
Córdoba, X5008KKF
Clinica Privada del Prado
Córdoba, X5020AAA
Centro Universitario de Investigacion Corrientes
Corrientes, W3400
CIPADI
Godoy Cruz, 5501
Centro Medico Dr. Javier Marino
Haedo, B1706CZA
Hospital Italiano de La Plata
La Plata, B1900AXI
Unidad de Cardiologia Clinica
Mar del Plata, B7600FEN
Hospital Privado de Comunidad
Mar del Plata, B7602CBM
Hospital Central de Mendoza, Mendoza
Mendoza, 5500
Hospital San Martin
Paraná, E3100BBJ
Sanatorio San Martin S.A., Venado Tuerto
Pellegrini, S2600KUE
CER Instituto Médico
Quilmes, B1878DVB
Instituto de Investigaciones Clínicas de Quilmes
Quilmes, B1878GEG
Instituto de Investigaciones Clinicas de Rosario
Rosario, 2000
Instituto Medico de la Fundacion Estudios Clinicos, Rosario
Rosario, 2000
Instituto Medico Fundación Grupo Colaborativo Rosario
Rosario, 2000
Sanatorio Británico
Rosario, 2000
Sanatorio Norte
Rosario, 2000
Instituto de Hematologia y Medicina Clinica Ruben Davoli
Rosario, CP2000
Sanatorio Delta
Rosario, S2000BIF
Centro Medico CIR
Rosario, S2000DEJ
CEDyN
Rosario, S2000DNM
Instituto CAICI
Rosario, S2000PBJ
Instituto Medico CENICLAR-C de Investigaciones Clinicas
Rosario, S2000QID
Centro Cardiovascular Salta
Salta, 4406
CORDIS S.A., Salta
Salta, A4400ANW
Prevencion Cardiovascular Salta, Salta
Salta, A4400CRC
Investigaciones Clinicas Tucuman
San Miguel de Tucumán, T4000ICL
CCBR Tucuman
San Miguel de Tucumán, T4000
Instituto de Investigaciones Clinicas San Nicolas
San Nicolás, B2900DMH
Centro Medico Luquez
San Vicente, X5006CBI
Hospital "Dr. José Maria Cullen "
Santa Fe, S3000EOZ
Centro de Investigaciones Clínicas del Litoral
Santa Fe, S3000FWO
Clinica Privada Fusavim SRL
Villa María, X5900JKA
Instituto de Investigaciones Clínicas Zárate
Zárate, 2800
Brazil39 sites
Hospital Universitário João de Barros Barreto
Belém, 66073-000
Hospital Felício Rocho
Belo Horizonte, 30110-060
Hospital Lifecenter
Belo Horizonte, 30110-921
Hospital Vera Cruz
Belo Horizonte, 30140-062
Hospital Angelina Caron
Campina Grande do Sul, 83430-000
HMCP - Hospital e Maternidade Celso Pierro - PUC-Campinas
Campinas, 13060-904
CAEP - Centro Avançado de Estudos e Pesquisas Ltda.,Campinas
Campinas, 13087-567
Hospital Universitário
Canoas, 92425-900
Universidade de Caxias do Sul - IPCEM - Inst. de Pesq.clilni
Caxias do Sul, 95070-560
Hospital de Caridade Santa Casa de Misericordia de Curitiba
Curitiba, 80010-030
HC UFPR
Curitiba, 80030-110
Cruz Vermelha Brasileira - Filial do Estado do Paraná
Curitiba, 80030-480
Centro de Estudos em Diabetes e Hipertensão
Fortaleza, 60115-282
Centro de Pesquisas em Diabetes e Doenças
Fortaleza, 60430-350
ICE-HUWC - Instituto Cearense de Endocrinologia
Fortaleza, 60430-370
Via Médica
Goiânia, 74223-130
Hospital Bruno Born
Lajeado, 95900-000
ICM - Instituto do Coração de Marília
Marília, 17515-000
Hospital São Vicente de Paulo
Passo Fundo, 99010-080
Irmandade da Santa Casa de Misericórdia de Porto Alegre
Porto Alegre, 90035-074
Centro de Pesquisas em Diabetes
Porto Alegre, 90035-170
Instituto de Cardiologia Rio Grande do Sul
Porto Alegre, 90620-001
Centro de Pesquisas Médicas Básica e Clínica Ltda
Recife, 52020-010
CCBR - Rio de Janeiro - BR
Rio de Janeiro, 22271-100
Centro de Pesquisa Clínica Santa Maria
Santa Maria, 97015-530
CCBR Brasil - São Paulo
Santo André, 09190510
Instituto Domingo Braile
São José do Rio Preto, 15015-750
Fundacao Faculdade Regional de Medicina, Sao Jose
São José do Rio Preto, 15090-000
Cpquali Pesquisa Clinica Ltda
São Paulo, 01228-000
Centro de Pesquisa Clinica - CPCLIN
São Paulo, 01244-030
Hospital Alemao Oswaldo Cruz
São Paulo, 01323-903
FGM Clínica Paulista de Doenças Cardiovasculares LTDA
São Paulo, 01327-010
Hospital Sao Paulo - UNIFESP
São Paulo, 04022-001
Hospital do Servidor Público Estadual
São Paulo, 04039-901
Dr. Consulta
São Paulo, 04254-020
Hospital das Clinicas da FMUSP
São Paulo, 05403-000
Incor - Instituto do Coração - HCFMUSP
São Paulo, 05403-000
IMC - Instituto de Moléstias Cardiovasculares Tatuí
Tatuí, 18270-170
ICT - Instituto do Coração do Triângulo
Uberlândia, 38400-368
Poland32 sites
B_Serwis Popenda Sp.Jawna
Chorzów, 41-500
Poradnia Kardiologiczna Jaroslaw Jurowiecki
Gdansk, 80-286
University Clinical Center, Gdansk
Gdansk, 80-952
Indywidualna Specjalistyczna Praktyka Lekarska
Gdynia, 81-157
MCBK Iwona Czajkowska Anna Podrazka- Szczepaniak S.C.
Grodzisk Mazowiecki, 05-825
Centrum Medyczne Pratia Katowice II
Katowice, 40-084
Polimedica Centrum Bada?, Profilaktyki I Leczenia
Kielce, 25-364
NZOZ Centrum Medyczne ProMiMed Sp. z o.o., Sp.k., Krakow
Krakow, 31-637
Centrum Terapii Wspolczesnej J.M.
Lodz, 90-242
CCBR - Lodz - PL, Lodz
Lodz, 90-368
Individual Specialized Practice
Lodz, 94-255
Centrum Medyczne "Luxmed" Sp. z o.o.
Lublin, 20-109
KO-MED Centra Kliniczne Lublin II
Lublin, 20-362
NZOZ Specialized Ambulance "MEDICA"
Lublin, 20-538
RCMed- Regionalne Centrum Medyczne
Nowy Duninów, 09-505
Medicome Sp. z o.o.
Oświęcim, 32-600
Prywatny Gabinet Lekarski Lech Lazuka
Parczew, 21-200
Clin.Hosp.Med.Univ.Marcinkowski in Poznan
Poznan, 60-569
Praktyka Lekarska Ewa Krzyzagorska
Poznan, 61-655
KOMED Marek Konieczny
Puławy, 24-100
Indywidualna Specjalistyczna Praktyka Lekarska Dr N Med Andrzej Wittek
Ruda Śląska, 41-709
Centrum Medyczne Medyk
Rzeszów, 35-055
RCMed- Regionalne Centrum Medyczne
Sochaczew, 96-500
NSZOZ Medicus
Środa Wielkopolska, 63-000
KO-MED Centra Kliniczne Staszow
Staszów, 28-200
Lecznice Citomed Sp. z o.o.
Torun, 87-100
NZOZ Nasz Lekarz
Torun, 87-100
NBR Polska
Warsaw, 00-465
CCBR/Somed - Warszaw - PL
Warsaw, 04-730
Regionalna Poradnia Diabetoloiczna Zytkiewicz-Jaruga
Wroclaw, 50-127
KO-MED Centra Kliniczne Zamosc
Zamość, 22-400
Polimedica Centrum Bada?, Profilaktyki I Leczenia
Zgierz, 95-100
Canada28 sites
LMC Endocrinology Centres (Barrie) Ltd.
Barrie, Ontario, L4N 7L3
ViaCar Recherche Clinique Inc
Brossard, Quebec, J4Z 2K9
JBN Medical Diagnostic Services Inc.
Burlington, Ontario, L7M 4Y1
Dr. Ronald Collette
Burnaby, British Columbia, V5G 1T4
ALTA Clinical Research Inc.
Edmonton, Alberta, T5A 4L8
LMC Endocrinology Centres (Etobicoke) Ltd.
Etobicoke, Ontario, M9R 4E1
Medicor Research
Greater Sudbury, Ontario, P3E 1H5
Sudbury Cardiac Research
Greater Sudbury, Ontario, P3E 2N8
Dr. R. Labonte Prof. Med. Corp
Greater Sudbury, Ontario, P3E 3B8
Hopital Charles - LeMoyne
Greenfield Park, Quebec, J4V 2G9
True North Clinical Research Halifax, Inc.
Halifax, Nova Scotia, B3S 1M7
Centre De Recherche Clinique
Laval, Quebec, H7T 2P5
Recherche Invascor Inc.
Longueuil, Quebec, J4N 1C2
LMC Endocrinology Centres (Markham) Ltd.
Markham, Ontario, L6B 0P9
Centre Hospitalier de l'Universite de Montreal (CHUM)
Montreal, Quebec, H2X 0A9
McGill University Health Centre (MUHC)
Montreal, Quebec, H4A 3J1
SKDS Research Incorporated
Newmarket, Ontario, L3Y 5G8
The Medical Arts Health Research Group
Penticton, British Columbia, V2A5G8
Recherche Clinique Sigma Inc.
Québec, G1G 3Y8
Clinique des maladies Lipidiques de Quebec
Québec, G1V 4M6
The Bailey Clinic
Red Deer, Alberta, T4N 6V7
St Jerome Medical Research Inc.
Saint-Jérôme, Quebec, J7Z 5T3
LMC Endocrinology Centres (Montreal)
Saint-Laurent, Quebec, H4T 1Z9
LMC Clinical Research dba Manna Research Inc. Vancouver
Vancouver, British Columbia, V6J 1S3
Fraser Clinical Trials Inc.
Victoria, British Columbia, V8R 4R2
Discovery Clinical Services Ltd.
Victoria, British Columbia, V8T 5G4
CookMed Research
Victoria, British Columbia, V8V 4A1
Winnipeg Regional Health Authority, Winnipeg
Winnipeg, Manitoba, R3E 3P4
South Africa23 sites
Cardiology Clinical Research
Alberton, 1449
Iatros International
Bloemfontein, 9301
Limaro Research
Bloemfontein, 9301
Dr JM Engelbrecht Practice
Cape Town, 7129
Dr Dawood, Mohamed and Pillay
Cape Town, 7405
TREAD Research
Cape Town, 7500
Langeberg Clinical Trials
Cape Town, 7570
Cape Town Medical Research Centre
Cape Town, 7580
Ismail, SM
Cape Town, 7764
Groote Schuur Hospital
Cape Town, 7925
Latiff, GHVM
Durban, 4001
Londisizwe Research Centre, Durban
Durban, 4001
Diabetes Care Centre
Johannesburg, 1501
Wits Clinical Research Chris Hani Baragwanath Hospital
Johannesburg, 2013
WCR CMJAH Clinical Trial Site
Johannesburg, 2193
DJW Navorsing
Krugersdorp, 1739
Emmed Research
Pretoria, 0002
University of Pretoria
Pretoria, 0002
Syzygy Clinical Research Services
Pretoria, 0087
Into Research
Pretoria, 181
Seeber, M
Pretoria, 2
Dr M Duki Research and Trial Site, Verulam
Verulam, 4339
Clinical Projects Research
Worcester, 6850
Ukraine23 sites
Chernivtsi Regional Endocrinology Dispensary
Chernivtsi, 58022
Regional CH Dept of Endocrinology SHEI Ivano-Frankivsk NMU
Ivano-Frankivsk, 76008
CI Ivano-Frankivsk Reg Cl Card Center
Ivano-Frankivsk, 76018
L.T. Malaya Institute of Therapy AMS of Ukraine
Kharkiv, 61039
CIPH Prof. O.I. Meshchaninov Kharkiv CCH of A&E
Kharkiv, 61103
CI of Healthcare Kharkiv CCH #8, Kharkiv
Kharkiv, 61176
KCCC of Endocr Dept of General Endocrine Pathology
Kyiv, 01004
City Clinical Hospital No. 1, Kiev
Kyiv, 02091
V.P. Komisarenko Inst. of Endocrinology and Metabolism
Kyiv, 04114
Kjiv City Oleksandrivska Clinical Hospital
Kyiv, 1601
LLC Treatment and Diagnostic Center Adonis Plus, Kyiv
Kyiv, 2002
SI National Scientific Centre of Radiation Medicine of NAMSU
Kyiv, 3115
P.L. Shupyk NMA of PGE Ch of D H for S-ts of NASU
Kyiv, 4050
SI V.P.Komisarenko Institute of Endocrinology and Metabolism
Kyiv, 4114
Lviv Regional Endocrinology Dispensary
Lviv, 79010
M.V. Sklifosovskyi Poltava RCH, Poltava
Poltava, 36011
CI Sumy City Clinical Hospital #1 Dept of Therapy Sumy SU
Sumy, 40021
CI of TRC Ternopil UH
Ternopli, 46002
Private Small Enterprise Medical Center Pulse
Vinnytsia, 21001
Vinnytsia RC Highly Special.Endocr.Center Dept of Therapy
Vinnytsia, 21010
M.I. Pyrogov VRCH, Vinnytsia
Vinnytsia, 21018
CCH #1 M.I. Pyrogov VNMU Ch of Propaedeutics of IM
Vinnytsia, 21021
CI Zapor CCH#10 SI ZMA PGE Ch of therapy clin pharmacol & endocrin
Zaporizhzhya, 69001
Russia22 sites
SBEI HPE Altay State Medical University of MoH and SD
Barnaul, 656038
Res.Inst.-Compl.Iss.Cardi.Dis.
Kemerovo, 650002
NSIH "Departmental Hospital on Station Kemerovo of OJSC "Russian Railways"
Kemerovo, 650055
First Moscow State Medical University n.a. I.M. Sechenov
Moscow, 119435
Moscow 1st State Med.Univ.n.a.I.M.Sechenov
Moscow, 119992
SBEI HPE "Moscow State Medical and Dentistry University
Moscow, 127473
Moscow State Medical Dentistry University
Moscow, 129301
SBIH of Novosibirsk Region "Clinical Emergency Hospital #2"
Novosibirsk, 630008
Novosibirsk Regional Clinical Cardiological Dispansary
Novosibirsk, 630047
FSBSI "Scientific Research Institute", Novosibirsk
Novosibirsk, 630089
FSBSI "Scientific and Research Institute of Physiology and Basic Medicine"
Novosibirsk, 630117
BIH of OR "City Hospital # 2", Omsk
Omsk, 644021
SBIH of Perm territory " City Clinical Hospital # 2 n.a.
Perm, 614068
SBI of Ryazan region "Regional Clinical Cardiological Dis.
Ryazan, 390026
FSBMEI HPE "Military Medical Academy n.a. S.M. Kirov"
Saint Petersburg, 194044
Medical Research Institute LLC, St. Petersburg
Saint Petersburg, 196084
1stPavlov St.Med.Univ.St.-Petersburg Res.Inst.
Saint Petersburg, 197022
Federal North-West Medical Research Centre
Saint Petersburg, 197341
SPb SBHI "City Policlinic #74"
Saint Petersburg, 197762
SPb SBIH "City Pokrovskaya Hospital"
Saint Petersburg, 199106
GUZ "City Clinical Hospital #40, 197706 Saint-Petersburg
Sestroretsk, 197706
FSBI "Research Institute for Cardiology"
Tomsk, 634012
Mexico21 sites
Investigación en Salud y Metabolismo S.C.
Chihuahua City, 31237
Phylasis Clinicas Research S de RL de CV
Cuautitlán Izcalli, 54769
Centro para el Desarrollo de la Medicina y de Asist Med Espe
Culiacán, CP80020
Centro de Investigacion Biomedica y Farmaceutica, S.C.
Distrito Federal, 03100
Servicios Medicos de la Pena SC
Guadalajara, 44690
Medical Care & Research SA de CV
Mérida, 97070
Sociedad de Cirugia Vascular Plastica Reconstructiva
Mérida, 97129
Phytomedicamenta S.A. de C.V.
México, 03100
Comite Mexicano Para la Prevencion de Osteoporosis AC
México, 06100
Centro de Atención e Investigación en Factores de Riesgo
México, 06700
Clinstile S.A. de C.V.
México, 06700
Ultimate Medica SA de CV
México, 11850
Health Pharma Professional Research S.A. de C.V.
México, 3810
Centro de Estudios Clinicos y Especialidades Medicas, S.C.
Monterrey, 64620
AVIX Investigación Clínica S.C
Monterrey, 64710
Global Trial Research Center S.A. de C.V.
Monterrey, 64718
Centro de Investigacion Clinica Chapultepec S. A. de C. V.
Morelia, 58260
Centro de Estudios Clínicos de Queretaro S.C., CECLIQ
Querétaro, 76000
Centro de Investigacion Cardiovascular y Metabolica
Tijuana, 22500
Centro de Investigación Médica de Ocidente, S.C.
Zapopan, 45116
Hospital Dr Angel Leano
Zapopan, 45200
Romania21 sites
SC Diana Barbonta SRL, Alba Iulia
Alba Iulia, 510053
Spitalul Universitar de Urgenta, Bucuresti
Bucharest, 010825
I.N.D.N.B.M. "Prof. Dr. N.C. Paulescu" - Sediul Central
Bucharest, 011234
I.N.D.N.B.M. "Prof. Dr. N.C. Paulescu" - Sediul Central
Bucharest, 020475
CMI Dr. Stolea T. Violeta
Bucharest, 061072
Clinica Medicala Data Plus SRL
Bucharest, 10192
I.N.D.N.B.M. "Prof. Dr. N.C. Paulescu" - Sediul "I.L. Caragiale"
Bucharest, 20045
S.C Centrul Medical "Sanatatea Ta" S.R.L
Bucharest, 20614
S.C. Policlinica CCBR SRL, Bucuresti
Bucharest, 30463
Medcon SRL
Buzău, 120203
Spitalul Clinic Judetean de Urgenta ¿Sf. Apostol Andrei¿
Galati, 800578
Spitalul Clinic, Iasi
Iași, 700503
Consultmed SRL, Iasi
Iași, 700547
SC Diaconu-Sotropa Michaela, Cabinet de Diabet
Iași, 700613
S.C Grandmed S.R.L, Oradea
Oradea, 410159
Pelican Impex SRL, Cabinet Nr. 15
Oradea, 410469
S.C Anamed S.R.L
Oradea, 410491
S.C. Diabmed Dr. Popescu Alexandrina S.R.L
Ploieşti, 100163
Gensan SRL
Sibiu, 550371
Mediab SRL
Târgu Mureş, 540142
Centrul Medical Dr Negrisanu SRL
Timișoara, 300456
Hungary19 sites
Lausmed Kft. Outpatient Unit of Internal Medicine
Baja, 6500
Dr. Kenessey Albert Kórház-Rendelõintézet, Balassagyarmat
Balassagyarmat, 2660
DRC Gyogyszervizsgalo Kozpont Kft., Balatonfured
Balatonfüred, 8230
Clinexpert Kft.
Budapest, 1033
Obudai Egeszsegugyi Centrum
Budapest, 1036
QUALICLINIC Kft
Budapest, 1036
Semmelweis Egyetem, Budapest
Budapest, 1083
Semmelweis Egyetem, Budapest
Budapest, 1088
Semmelweis Egyetem, Budapest
Budapest, 1125
University Debrecen Hospital
Debrecen, 4032
Markhot Ferenc Hospital, Eger
Eger, 3300
Csongrad Megyei Eu. Ellato Kozp. Hodmezovasarhely-Mako
Hódmezővásárhely, 6800
Somogy Megyei Kaposi Mor Oktato Korhaz, Kaposvar
Kaposvár, 7400
Selye Janos Hospital Komarom
Komárom, 2900
Ermellek Egeszsegcentrum
Létavértes, 4281
Borsod-Abauj-Zemplen Megyei Korhaz es Egyetemi Oktato Korhaz
Miskolc, 3526
Pecsi Tudomanyegyetem
Pécs, 7624
Szegedi Tudomanyegyetem Szent-Gyorgyi Albert Klin. Kozpont
Szeged, 6725
Zala Megyei Szent Rafael Korhaz
Zalaegerszeg, 8900
Czechia17 sites
Fakultni nemocnice u sv. Anny v Brne
Brno, 656 91
Fakultni nemocnice u sv. Anny v Brne
Brno, 65691
Revmatologie Bruntal, s.r.o.
Bruntál, 792 01
Poliklinika Chocen, a.s.
Choceň, 56501
Aesculap Ambulance Sro
Dolní Břežany, 252 41
OKELI s.r.o.
Hodonín, 695 01
Nemocnice Jindrichuv Hradec a.s.
Jindřichův Hradec, 377 01
Regional Hospital Liberec
Liberec, 460 63
InterKardioML s.r.o.
Mariánské Lázně, 353 01
Interna a diabetologicka ordinace s.r.o.
Náchod, 547 01
PreventaMed, s.r.o.
Olomouc, 77900
Univ. Hospital Kralovske Vinohrady
Prague, 100 34
Vseobecna fakultni nemocnice V Praze
Prague, 128 08
ResTrial s.r.o.
Prague, 181 00
Thomayer Hospital
Praha 4 - Krc, 140 59
Hospital Slany, Internal Department
Slaný, 274 01
Krajska zdravotni, a.s. - Nemocnice Teplice, o.z.
Teplice, 41501
Colombia15 sites
CEQUIN
Armenia, 55860
Corazon IPS S.A.S.
Barranquilla, 0000
Clínica de la Costa Ltda.
Barranquilla, 0
IPS Centro Cientifico Asistencia
Barranquilla, 80020
Centro de Atencion e Investigacion Medica S.A. - CAIMED
Bogotá, 0
CAFESALUD Medicina Prepagada S.A.
Bogotá, 110221
Dexa Diabetes Servicios Médicos Ltda
Bogotá, 110221
Solano y Terront Servicios Médicos Ltda.
Bogotá, 110221
Fundacion Reina Isabel
Cali, 0
IPS Centro Medico Julián Coronel S.A.
Cali, 0
Fundación Centro de Investigaciones Biomédicas Riescard
Espinal, 0
Centro de Investigacion Clínica Avanzada
Medellín, 0
Fundacion Centro de Investigacion Clinica CIC, Medellin
Medellín, 50021
Fundacion Centro de Obesidad y Metabolismo - COMETA
Pasto, 52002
Healthy Medical CenterS.A.S, Zipaquirá
Zipaquirá, 0
Spain15 sites
Hospital Virgen del Mar
Almería, 04120
Hospital de la Ribera
Alzira, 46600
Hospital Germans Trias i Pujol
Badalona, 08916
Specialist
Barcelona, 08006
CAP Sarria
Barcelona, 08017
Hospital Quiron. I.C.U.
Barcelona, 08023
EBA Centelles
Centelles, 08540
Fundación Jiménez Díaz
Madrid, 28040
Hospital Regional Universitario de Málaga
Málaga, 29010
Hospital General de Segovia
Segovia, 40002
Hospital Quironsalud Infanta Luisa
Seville, 41010
Hospital Virgen Macarena
Seville, 41071
Hospital General Universitario de Valencia
Valencia, 46014
Hospital Dr. Peset
Valencia, 46017
Hospital Virgen de las Montañas, Villamartin
Villamartín, 11650
United Kingdom13 sites
University Hospital Monklands
Airdrie, ML6 0JS
Queen Elizabeth Hospital
Birmingham, B15 2TH
Bradford on Avon Health Centre
Bradford on Avon, BA15 1DQ
Ashgate Medical Practice
Chesterfield, S40 4AA
Dumfries and Galloway Royal Infirmary
Dumfries, DG1 4AP
Ninewells Hospital & Medical School
Dundee, DD1 9SY
Royal Devon and Exeter Hospital
Exeter, EX2 5DW
Glasgow Royal Infirmary
Glasgow, G4 0SF
Leicester General Hospital
Leicester, LE5 4PW
Barts and The London School of Medicine and Dentistry
London, EC1M 6BQ
Morriston Hospital
Swansea, SA6 6NL
Queen Elizabeth II Hospital
Welwyn Garden City, AL7 4HQ
New Cross Hospital
Wolverhampton, WV10 0QP
South Korea12 sites
Hallym University Sacred Heart Hospital
Anyang-si, 431-070
Inje University Busan Paik Hospital
Busan, 47392
Dong-A University Hospital
Busan, 602-715
Pusan National Univ. Hosp
Busan, 602-739
Myongji Hospital
Goyang-si, 412-270
Gachon University Gil Medical Center
Incheon, 21565
The Catholic University of Korea, Seoul St.Mary's Hospital
Seoul, 06591
Seoul National University Hospital
Seoul, 110744
Asan Medical Center
Seoul, 138736
Korea University Anam Hospital
Seoul, 2841
Korea University Guro Hospital
Seoul, 8308
Wonju Severance Christian Hosp
Wŏnju, 26426
Bulgaria10 sites
MHAT - Blagoevgrad, EOOD
Blagoevgrad, 2700
MHAT "Yuliya Vrevska" EOOD, Byala
Byala, 7100
MHAT "Dr.Stambolski", Cardiology&Intensiv Care Dept,Kazanlak
Kazanlak, 6100
UMHAT "Kaspela", EOOD, Plovdiv
Plovdiv, 4002
DCC 1 - Ruse, EOOD
Rousse, 7002
Fifth MHAT - Sofia EAD, Sofia
Sofia, 1233
MHAT Lyulin
Sofia, 1336
MHAT 'Tokuda Hospital Sofia', EAD
Sofia, 1407
USHATE Hospital 'Academy Ivan Penchev', Sofia
Sofia, 1431
DCC "Equita" EOOD
Varna, 9000
Israel10 sites
Haemek Medical Center
Afula, 18101
Bnei Zion Medical Center, Haifa
Haifa, 31048
Rambam Medical Center
Haifa, 3109601
Herzliya Medical Center
Herzliya, 4685107
Wolfson Medical Center
Holon, 58100
Hadassah Medical Center, Ein-Karem
Jerusalem, 9112001
Meir Medical Center
Kfar Saba, 4428164
Galilee Medical Center
Nahariya, 2210001
Ziv Medical Center
Safed, 13100
Sourasky Medical Center
Tel Aviv, 6423906
Japan10 sites
Daishinkai Medical Corporation Ookuma Hospital
Aichi, Nagoya, 462-0825
Seikeikai New Tokyo Heart Clinic
Chiba, Matsudo, 271-0077
Saiseikai Matsuyama Hospital
Ehime, Matsuyama, 791-8026
Aso Co.,Ltd Iizuka Hospital
Fukuoka, Iizuka, 820-8505
Kitakyushubyoin Kitakyushu General Hospital
Fukuoka, Kitakyushu, 800-0295
The Veritas Hospital
Hyogo, Kawanishi, 666-0125
Ibaraki Seinan Medical Center Hospital
Ibaraki, Sashima-gun, 306-0433
Kokan Clinic
Kanagawa, Kawasaki, 210-0852
Nagano Red Cross Hospital
Nagano, Nagano, 380-8582
Josuikai Olive Takamatsu Medical Clinic
Takamatsu, 760-0076
Malaysia10 sites
Hospital Sultanah Bahiyah
Alor Star, 5460
Hospital Tengku Ampuan Rahimah
Klang, 41200
University Malaya Medical Centre
Kuala Lumpur, 59100
Hospital Tengku Ampuan Afzan
Kuantan, 25100
Monash University(Sunway Campus)
Petaling Jaya, 46150
Hospital Pulau Pinang
Pulau Pinang, 10450
Universiti Putra Malaysia
Serdang, 43400
Hospital Seri Manjung
Seri Manjung, 32040
Hospital Taiping
Taiping, 34000
Klinik Kesihatan Tampin
Tampin, 73009
Netherlands10 sites
Rijnstate Hospital
Arnhem, 6815 AD
Albert SchweitzerZiekenhuis
Dordrecht, 3318 AT
Universitair Medisch Centrum Groningen
Groningen, 9713 GZ
Martini Ziekenhuis
Groningen, 9728 NT
Bethesda Cardiology Group, Hoogeveen
Hoogeveen, 7909 AA
Maastricht Universitair Medisch Centrum
Maastricht, 6229 HX
Rotterdam Research Institute
Rotterdam, 3039 BD
Universitair Medisch Centrum Utrecht
Utrecht, 3584 CX
TweeSteden Ziekenhuis
Waalwijk, 5141 BM
Gelre Ziekenhuis Zutphen
Zutphen, 7207 BA
Chile9 sites
Hospital Regional de Punta Arenas Dr. Lautaro Navarro Avaria
Punta Arenas, 6200000
Hospital El Pino
Santiago, 0
Sociedad Medica Cardiologica El Llano
Santiago, 0
Hospital Militar de Santiago
Santiago, 7850000
Hospital Sotero del Rio
Santiago, 8150000
CeCim - Centro de Estudios Clinicos e Investigacion Medica
Santiago, 8331143
Hospital Padre Alberto Hurtado
Santiago, 8880465
Hospital Base Valdivia
Valdivia, 5090000
Hospital Naval Almirante Nef
Viña del Mar, 2520000
China8 sites
Beijing Jishuitan Hospital
Beijing, 100035
Third Affiliated Hospital of Guangzhou Medical University
Guangzhou, 510150
Zhejiang University School of Medicine SIR RUN RUN SHAW Hospital
Hangzhou, 310016
Center Hospital of Jinan
Jinan, 250013
People's Hospital of Guangxi Zhuang Autonomous Region
Nanning, 530021
Tongji Hospital, Tongji University
Shanghai, 200065
First Affiliated Hospital of Xi'an JiaoTong University
Xi'an, 710061
General Hospital of Ningxia Medical University
Yinchuan, 750004
Germany8 sites
Studienzentrum Aschaffenburg
Aschaffenburg, 63739
Zentrum für klinische Forschung Dr. med. Irma Schöll & Kollegen
Bad Homburg, 61348
Universitätsklinikum Carl Gustav Carus Dresden
Dresden, 1307
ClinPhenomics GmbH & Co KG, Frankfurt
Frankfurt, 60594
IKF Pneumologie GmbH & Co. KG
Frankfurt am Main, 60596
Diabetologische Schwerpunktpraxis, Hohenmölsen
Hohenmölsen, 6679
EUGASTRO GmbH, Leipzig
Leipzig, 4103
Gemeinschaftspraxis Dr. Taeschner / Dr. Bonigut, Leipzig
Leipzig, 4249
Taiwan8 sites
Kaohsiung Medical University Chung-Ho Memorial Hospital
Kaohsiung City, 807
Kaohsiung Veterans General Hospital
Kaohsiung City, 81362
Far Eastern Memorial Hospital
New Taipei City, 220
China Medical University Hospital
Taichung, 404
NCKUH
Tainan, 704
National Taiwan University Hospital
Taipei, 100
Taipe Veterans General Hospital
Taipei, 11217
Chang-Gung Memorial Hospital, Linkou
Taoyuan County, 333
Croatia7 sites
General Hospital Karlovac
Karlovac, 47000
Hospital for Medical Rehabilitation, Krapinske Toplice
Krapinske Toplice, 49217
General Hospital Slavonski Brod
Slavonski Brod, 35000
General Hospital Varazdin
Varaždin, 42000
General Hosp. Zadar, Dept. of Internal Medicine-Pulmonology
Zadar, 23000
Clinical Hospital Sveti Duh
Zagreb, 10000
University hospital center Zagreb
Zagreb, 10000
Portugal7 sites
Hospital de Braga-Escala Braga
Braga, 4710-243
CHUC - Centro Hospitalar e Universitário de Coimbra, EPE
Coimbra, 3000-075
APDP - Associação Protectora dos Diabéticos de Portugal
Lisbon, 1250-203
CHLO, EPE - Hospital S. Francisco Xavier
Lisbon, 1449-005
Hospital da Luz
Lisbon, 1500-650
Hospital CUF Porto
Porto, 4100-180
Centro Hospitalar de Vila Nova de Gaia
V. N. Gaia, 4434-502
About this study
Official title: CARMELINA: A Multicenter, International, Randomized, Parallel Group, Double-blind, Placebo-controlled, Cardiovascular Safety and Renal Microvascular Outcome Study With Linagliptin, 5 mg Once Daily in Patients With Type 2 Diabetes Mellitus at High Vascular Risk
The aim of the study is to investigate the longterm impact on cardiovascular morbidity, mortality and renal function of treatment with linagliptin in a selected population of patients with Type 2 diabetes mellitus (T2DM) and to compare outcomes against placebo, on a background of standard of care.
- Conditions
- Diabetes Mellitus, Type 2
- Being tested
- Placebo, Linagliptin
- Medical subject headings
- Diabetes Mellitus, Type 2
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
PlaceboDrug
placebo matching tablets
LinagliptinDrug
| Study group | Role | What they receive |
|---|---|---|
| Linagliptin | Experimental | Not described Receives: Drug: Linagliptin |
| Placebo | Placebo comparator | Not described Receives: Drug: Placebo |
What is being measured
The primary outcome is the main question the study is designed to answer.
Time to the First Occurrence of Any of the Following Adjudication-confirmed Components of the Primary Composite Endpoint 3-point Major Adverse Cardiovascular (CV) Events (3-point MACE): CV Death, Non-fatal Myocardial Infarction (MI) or Non-fatal Stroke.
Time to event analysis of patients with first occurrence of any of the following adjudication-confirmed components of the primary composite endpoint (3-point MACE): CV death, non-fatal MI or non-fatal stroke. The percentage of observed patients with first occurrence of any of the following adjudication-confirmed components of the primary composite endpoint (3-point MACE) was reported.
Measured: From randomization to individual end of observation; up to 4.3 years
Secondary outcomes (1)
Time to the First Occurrence of Any of the Following Adjudication-confirmed Components: Renal Death, Sustained End Stage Renal Disease (ESRD), or Sustained Decrease of 40% or More in Estimated Glomerular Filtration Rate (eGFR).
Time to the first occurrence of any of the following adjudication-confirmed components: renal death, sustained ESRD, or sustained decrease of 40% or more in eGFR.
The percentage of observed patients with first occurrence of any of the following adjudication-confirmed components: renal death, sustained ESRD, or sustained decrease of 40% or more in eGFR was reported.
Measured: From randomization to individual end of observation; up to 4.3 years
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted12 Jul 2013 (estimated)
- Study start10 Jul 2013
- Primary completion18 Jan 2018
- Study completion18 Jan 2018
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Posted resultsParticipant flow, outcome measures and adverse events reported by the sponsor.
- Publications (10)Papers the sponsor has linked to this study.
- Other trials for Diabetes Mellitus, Type 2Studies of the same condition, open and under way.
- More trials run by Boehringer IngelheimThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase 4
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind
- Who is masked
- Participant, Investigator
- Enrolment
- 6,991 participants (actual)
Sponsor and investigators
- Lead sponsor
- Boehringer Ingelheim
- Sponsor type
- Industry (pharma, biotech, devices)
- Collaborators
- Eli Lilly and Company
- Responsible party
- Sponsor
- Investigators
- Boehringer Ingelheim, Study chair, Boehringer Ingelheim
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT01897532
- Sponsor's protocol ID
- 1218.22
- Other IDs
- 2011-004148-23
- Status last verified
- Mar 2019
- First submitted
- 9 Jul 2013
- Last updated
- 4 Apr 2019
- Results posted
- Yes, on ClinicalTrials.gov
Publications
Marx N, Kolkailah AA, Rosenstock J, Johansen OE, Cooper ME, Alexander JH, Toto RD, Wanner C, Espeland MA, Mattheus M, Schnaidt S, Perkovic V, Gollop ND, McGuire DK. Hypoglycemia and Cardiovascular Outcomes in the CARMELINA and CAROLINA Trials of Linagliptin: A Secondary Analysis of Randomized Clinical Trials. JAMA Cardiol. 2024 Feb 1;9(2):134-143. doi: 10.1001/jamacardio.2023.4602.
PubMed 38170502Balasubramanian P, Kernan WN, Sheth KN, Ofstad AP, Rosenstock J, Wanner C, Zinman B, Mattheus M, Marx N, Inzucchi SE. Baseline Cardiovascular Risk Factor Control in Patients With Type 2 Diabetes and Coronary Disease Versus Stroke: Secondary Analysis of Cardiovascular Outcome Trials. Stroke. 2023 Aug;54(8):2013-2021. doi: 10.1161/STROKEAHA.122.042053. Epub 2023 Jul 14.
PubMed 37449424Dar MS, Wanner C, Marx N, Ofstad AP, Mattheus M, Kaspers S, Beg SA. Cardiovascular outcomes trial data from EMPA-REG OUTCOME, CAROLINA and CARMELINA: Assessment of a novel staging system for type 2 diabetes. Diabetes Obes Metab. 2023 May;25(5):1372-1384. doi: 10.1111/dom.14989. Epub 2023 Mar 6.
PubMed 36700391Verhagen C, Janssen J, Minderhoud CA, van den Berg E, Wanner C, Passera A, Johansen OE, Biessels GJ. Chronic kidney disease and cognitive decline in patients with type 2 diabetes at elevated cardiovascular risk. J Diabetes Complications. 2022 Oct;36(10):108303. doi: 10.1016/j.jdiacomp.2022.108303. Epub 2022 Aug 31.
PubMed 36116359Verhagen C, Janssen J, Exalto LG, van den Berg E, Johansen OE, Biessels GJ. Diabetes-specific dementia risk score (DSDRS) predicts cognitive performance in patients with type 2 diabetes at high cardio-renal risk. J Diabetes Complications. 2020 Oct;34(10):107674. doi: 10.1016/j.jdiacomp.2020.107674. Epub 2020 Jul 16.
PubMed 32723590Perkovic V, Toto R, Cooper ME, Mann JFE, Rosenstock J, McGuire DK, Kahn SE, Marx N, Alexander JH, Zinman B, Pfarr E, Schnaidt S, Meinicke T, von Eynatten M, George JT, Johansen OE, Wanner C; CARMELINA investigators. Effects of Linagliptin on Cardiovascular and Kidney Outcomes in People With Normal and Reduced Kidney Function: Secondary Analysis of the CARMELINA Randomized Trial. Diabetes Care. 2020 Aug;43(8):1803-1812. doi: 10.2337/dc20-0279. Epub 2020 May 22.
PubMed 32444457Biessels GJ, Verhagen C, Janssen J, van den Berg E, Zinman B, Rosenstock J, George JT, Passera A, Schnaidt S, Johansen OE; CARMELINA Investigators. Effect of Linagliptin on Cognitive Performance in Patients With Type 2 Diabetes and Cardiorenal Comorbidities: The CARMELINA Randomized Trial. Diabetes Care. 2019 Oct;42(10):1930-1938. doi: 10.2337/dc19-0783. Epub 2019 Aug 9.
PubMed 31399442McGuire DK, Alexander JH, Johansen OE, Perkovic V, Rosenstock J, Cooper ME, Wanner C, Kahn SE, Toto RD, Zinman B, Baanstra D, Pfarr E, Schnaidt S, Meinicke T, George JT, von Eynatten M, Marx N; CARMELINA Investigators. Linagliptin Effects on Heart Failure and Related Outcomes in Individuals With Type 2 Diabetes Mellitus at High Cardiovascular and Renal Risk in CARMELINA. Circulation. 2019 Jan 15;139(3):351-361. doi: 10.1161/CIRCULATIONAHA.118.038352.
PubMed 30586723Rosenstock J, Perkovic V, Johansen OE, Cooper ME, Kahn SE, Marx N, Alexander JH, Pencina M, Toto RD, Wanner C, Zinman B, Woerle HJ, Baanstra D, Pfarr E, Schnaidt S, Meinicke T, George JT, von Eynatten M, McGuire DK; CARMELINA Investigators. Effect of Linagliptin vs Placebo on Major Cardiovascular Events in Adults With Type 2 Diabetes and High Cardiovascular and Renal Risk: The CARMELINA Randomized Clinical Trial. JAMA. 2019 Jan 1;321(1):69-79. doi: 10.1001/jama.2018.18269.
PubMed 30418475Rosenstock J, Perkovic V, Alexander JH, Cooper ME, Marx N, Pencina MJ, Toto RD, Wanner C, Zinman B, Baanstra D, Pfarr E, Mattheus M, Broedl UC, Woerle HJ, George JT, von Eynatten M, McGuire DK; CARMELINA(R) investigators. Rationale, design, and baseline characteristics of the CArdiovascular safety and Renal Microvascular outcomE study with LINAgliptin (CARMELINA(R)): a randomized, double-blind, placebo-controlled clinical trial in patients with type 2 diabetes and high cardio-renal risk. Cardiovasc Diabetol. 2018 Mar 14;17(1):39. doi: 10.1186/s12933-018-0682-3.
PubMed 29540217
Study at a glance
From the registry record, last updated by the sponsor on 4 Apr 2019. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- CARMELINA: A Multicenter, International, Randomized, Parallel Group, Double-blind, Placebo-controlled, Cardiovascular Safety and Renal Microvascular Outcome Study With Linagliptin, 5 mg Once Daily in Patients With Type 2 Diabetes Mellitus at High Vascular Risk
- ClinicalTrials.gov ID
- NCT01897532
- Acronym / sponsor ID
- 1218.22
- Conditions
- Diabetes Mellitus, Type 2
- Phase
- Phase 4
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 6,991 participants (actual)
- Lead sponsor
- Boehringer IngelheimIndustry (pharma, biotech, devices)
- Collaborators
- Eli Lilly and Company
- Study start
- 10 Jul 2013 (actual)
- Primary completion
- 18 Jan 2018 (actual)
- Study completion
- 18 Jan 2018 (actual)
- First posted
- 12 Jul 2013 (estimated)
- Results
- Posted 25 Jan 2019
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The aim of the study is to investigate the longterm impact on cardiovascular morbidity, mortality and renal function of treatment with linagliptin in a selected population of patients with Type 2 diabetes mellitus (T2DM) and to compare outcomes against placebo, on a background of standard of care.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Double blind (participant, investigator)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Linagliptin | Experimental | Drug: Linagliptin |
| Placebo | Placebo comparator | Drug: Placebo |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (8 listed)
- Documented diagnosis of T2DM before visit 1(screening).
- Male or female patients who are drug-naïve or pre-treated with any antidiabetic background medication, excluding treatment with Glucagon-like Peptide 1 (GLP-1) receptor agonists, Dipeptidyl-peptidase 4 (DPP-4) inhibitors or Sodium Glucose Linked Transporter 2 (SGLT-2) inhibitors if => consecutive 7 days.
- Stable antidiabetic background medication (unchanged daily dose) for at least 8 weeks prior to randomization. If insulin is part of the background therapy, the average daily insulin dose should not have changed by more than 10% within the 8 weeks prior to randomization compared with the daily insulin dose at randomization.
- HbA1c of => 6.5% and <= 10.0% at Visit 1 (screening)
- Age => 18 years at Visit 1(screening). For Japan only: Age => 20 years at Visit 1
Key exclusion criteria (13 listed)
- Type 1 diabetes mellitus.
- Treatment (=> 7 consecutive days) with GLP-1 receptor agonists, other DPP-4 inhibitors or SGLT-2 inhibitors prior to informed consent. Note: This also includes clinical trials where these antidiabetic drugs have been provided to the patient.
- Active liver disease or impaired hepatic function, defined by serum levels of either Alanine Transaminase (ALT) (SGPT), Aspartate transaminase (AST) (SGOT), or alkaline phosphatase (AP) => 3 x upper limit of normal (ULN) as determined at Visit 1.
- Estimated Glomerular filtration Rate (eGFR) <15 ml/min/1.73 m2 (severe renal impairment or End Stage Renal Disease (ESRD), Modification of Diet in Renal Disease (MDRD) formula), as determined during screening at Visit 1 and/or the need for maintenance dialysis.
- Any previous (or planned within next 12 months) bariatric surgery (open or laparoscopic) or intervention (gastric sleeve).
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Placeboplacebo matching tablets | Drug | Placebo |
| Linagliptin | Drug | Linagliptin |
Primary outcome
Time to the First Occurrence of Any of the Following Adjudication-confirmed Components of the Primary Composite Endpoint 3-point Major Adverse Cardiovascular (CV) Events (3-point MACE): CV Death, Non-fatal Myocardial Infarction (MI) or Non-fatal Stroke.
Time frame: From randomization to individual end of observation; up to 4.3 years
Time to event analysis of patients with first occurrence of any of the following adjudication-confirmed components of the primary composite endpoint (3-point MACE): CV death, non-fatal MI or non-fatal stroke. The percentage of observed patients with first occurrence of any of the following adjudication-confirmed components of the primary composite endpoint (3-point MACE) was reported.
1 secondary outcome
Time to the First Occurrence of Any of the Following Adjudication-confirmed Components: Renal Death, Sustained End Stage Renal Disease (ESRD), or Sustained Decrease of 40% or More in Estimated Glomerular Filtration Rate (eGFR).
Time frame: From randomization to individual end of observation; up to 4.3 years
Results and safety
Loading the posted results from ClinicalTrials.gov…
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 4 Apr 2019.
- Posted resultsParticipant flow, baseline, all outcome measures and adverse events.
- Derived from this study: PubMed 38170502Marx N, Kolkailah AA, Rosenstock J, Johansen OE, Cooper ME, Alexander JH, Toto RD, Wanner C, Espeland MA, Mattheus M, Schnaidt S, Perkovic V, Gollop ND, McGuire DK. Hypoglycemia and Cardiovascular Outcomes in the CARMELINA and CAROLINA Trials of Linagliptin: A Secondary Analysis of Randomized Clinical Trials. JAMA Cardiol. 2024 Feb 1;9(2):134-143. doi: 10.1001/jamacardio.2023.4602.
- Derived from this study: PubMed 37449424Balasubramanian P, Kernan WN, Sheth KN, Ofstad AP, Rosenstock J, Wanner C, Zinman B, Mattheus M, Marx N, Inzucchi SE. Baseline Cardiovascular Risk Factor Control in Patients With Type 2 Diabetes and Coronary Disease Versus Stroke: Secondary Analysis of Cardiovascular Outcome Trials. Stroke. 2023 Aug;54(8):2013-2021. doi: 10.1161/STROKEAHA.122.042053. Epub 2023 Jul 14.
- Derived from this study: PubMed 36700391Dar MS, Wanner C, Marx N, Ofstad AP, Mattheus M, Kaspers S, Beg SA. Cardiovascular outcomes trial data from EMPA-REG OUTCOME, CAROLINA and CARMELINA: Assessment of a novel staging system for type 2 diabetes. Diabetes Obes Metab. 2023 May;25(5):1372-1384. doi: 10.1111/dom.14989. Epub 2023 Mar 6.
- Derived from this study: PubMed 36116359Verhagen C, Janssen J, Minderhoud CA, van den Berg E, Wanner C, Passera A, Johansen OE, Biessels GJ. Chronic kidney disease and cognitive decline in patients with type 2 diabetes at elevated cardiovascular risk. J Diabetes Complications. 2022 Oct;36(10):108303. doi: 10.1016/j.jdiacomp.2022.108303. Epub 2022 Aug 31.
- Derived from this study: PubMed 32723590Verhagen C, Janssen J, Exalto LG, van den Berg E, Johansen OE, Biessels GJ. Diabetes-specific dementia risk score (DSDRS) predicts cognitive performance in patients with type 2 diabetes at high cardio-renal risk. J Diabetes Complications. 2020 Oct;34(10):107674. doi: 10.1016/j.jdiacomp.2020.107674. Epub 2020 Jul 16.
- Derived from this study: PubMed 32444457Perkovic V, Toto R, Cooper ME, Mann JFE, Rosenstock J, McGuire DK, Kahn SE, Marx N, Alexander JH, Zinman B, Pfarr E, Schnaidt S, Meinicke T, von Eynatten M, George JT, Johansen OE, Wanner C; CARMELINA investigators. Effects of Linagliptin on Cardiovascular and Kidney Outcomes in People With Normal and Reduced Kidney Function: Secondary Analysis of the CARMELINA Randomized Trial. Diabetes Care. 2020 Aug;43(8):1803-1812. doi: 10.2337/dc20-0279. Epub 2020 May 22.
- Derived from this study: PubMed 31399442Biessels GJ, Verhagen C, Janssen J, van den Berg E, Zinman B, Rosenstock J, George JT, Passera A, Schnaidt S, Johansen OE; CARMELINA Investigators. Effect of Linagliptin on Cognitive Performance in Patients With Type 2 Diabetes and Cardiorenal Comorbidities: The CARMELINA Randomized Trial. Diabetes Care. 2019 Oct;42(10):1930-1938. doi: 10.2337/dc19-0783. Epub 2019 Aug 9.
- Derived from this study: PubMed 30586723McGuire DK, Alexander JH, Johansen OE, Perkovic V, Rosenstock J, Cooper ME, Wanner C, Kahn SE, Toto RD, Zinman B, Baanstra D, Pfarr E, Schnaidt S, Meinicke T, George JT, von Eynatten M, Marx N; CARMELINA Investigators. Linagliptin Effects on Heart Failure and Related Outcomes in Individuals With Type 2 Diabetes Mellitus at High Cardiovascular and Renal Risk in CARMELINA. Circulation. 2019 Jan 15;139(3):351-361. doi: 10.1161/CIRCULATIONAHA.118.038352.
- Derived from this study: PubMed 30418475Rosenstock J, Perkovic V, Johansen OE, Cooper ME, Kahn SE, Marx N, Alexander JH, Pencina M, Toto RD, Wanner C, Zinman B, Woerle HJ, Baanstra D, Pfarr E, Schnaidt S, Meinicke T, George JT, von Eynatten M, McGuire DK; CARMELINA Investigators. Effect of Linagliptin vs Placebo on Major Cardiovascular Events in Adults With Type 2 Diabetes and High Cardiovascular and Renal Risk: The CARMELINA Randomized Clinical Trial. JAMA. 2019 Jan 1;321(1):69-79. doi: 10.1001/jama.2018.18269.
- Derived from this study: PubMed 29540217Rosenstock J, Perkovic V, Alexander JH, Cooper ME, Marx N, Pencina MJ, Toto RD, Wanner C, Zinman B, Baanstra D, Pfarr E, Mattheus M, Broedl UC, Woerle HJ, George JT, von Eynatten M, McGuire DK; CARMELINA(R) investigators. Rationale, design, and baseline characteristics of the CArdiovascular safety and Renal Microvascular outcomE study with LINAgliptin (CARMELINA(R)): a randomized, double-blind, placebo-controlled clinical trial in patients with type 2 diabetes and high cardio-renal risk. Cardiovasc Diabetol. 2018 Mar 14;17(1):39. doi: 10.1186/s12933-018-0682-3.
- Related InfoLink provided by the sponsor.
Related trials for Diabetes Mellitus, Type 2
Not yet recruitingPhase 3
Efficacy and Safety of Once-Weekly SHR-3167 Compared With Once-Daily Insulin Glargine in Adults With Insulin-Naive Type 2 Diabetes
Type 2 Diabetes
Active, not recruiting
Digital Reinforcement of Motivational Interviewing Micro-Skills Among Primary Care Healthcare Professionals
Hypertension (Without Type 2 Diabetes Mellitus)
Recruiting
Investigating Vascular Properties of HEMI and SPG Signals in Individuals With or at Risk for Chronic Kidney Disease
Chronic Kidney Disease, Hypertension (HTN)
Not yet recruitingPhase 3
A Study to Evaluate the Effectiveness and Safety of the Drug AZD6234 for Managing Weight in Adults Who Are Obese or Overweight. These Participants May or May Not Also Have Type 2 Diabetes
Obesity, Overweight
Not yet recruiting
Impact of Endoscopic Sleeve Gastroplasty (ESG) in Obese Adults With Type 2 Diabetes (T2D)
Type 2 Diabetes Mellitus (T2D), Obesity (BMI>30)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Boehringer Ingelheim study chair
Boehringer Ingelheim
649 sites in 27 countries: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A Phase 4 study testing Linagliptin in people with Diabetes Mellitus, Type 2, run by Boehringer Ingelheim at 649 sites in 27 countries.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 8 inclusion and 13 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 4 Apr 2019. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 649 sites in United States, Argentina, Brazil, Poland, Canada and 22 more countries. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
What does this phase mean?
Phase 4 studies take place after a treatment is approved, to learn more about its long-term benefits and risks in everyday use.
Not every study follows the same path, and some studies (observational studies, device studies) have no phase.
Are results available for this study?
Yes. Results are posted in the registry (first posted 25 Jan 2019). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Time to the First Occurrence of Any of the Following Adjudication-confirmed Components of the Primary Composite Endpoint 3-point Major Adverse Cardiovascular (CV) Events (3-point MACE): CV Death, Non-fatal Myocardial Infarction (MI) or Non-fatal Stroke. (time frame: From randomization to individual end of observation; up to 4.3 years). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT01897532, which also lists 10 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 Apr 2019.